Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Malaria Vaccines Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Malaria Vaccines Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Pre-Erythrocytic Vaccine
      • 1.3.3 Erythrocytic Vaccine
      • 1.3.4 Multi-antigen Vaccine
    • 1.4 Market Segment by Application
      • 1.4.1 Global Malaria Vaccines Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Community Centers
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Malaria Vaccines Market Size
      • 2.1.1 Global Malaria Vaccines Revenue 2014-2025
      • 2.1.2 Global Malaria Vaccines Sales 2014-2025
    • 2.2 Malaria Vaccines Growth Rate by Regions
      • 2.2.1 Global Malaria Vaccines Sales by Regions 2014-2019
      • 2.2.2 Global Malaria Vaccines Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Malaria Vaccines Sales by Manufacturers
      • 3.1.1 Malaria Vaccines Sales by Manufacturers 2014-2019
      • 3.1.2 Malaria Vaccines Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Malaria Vaccines Revenue by Manufacturers (2014-2019)
      • 3.2.2 Malaria Vaccines Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Malaria Vaccines Market Concentration Ratio (CR5 and HHI)
    • 3.3 Malaria Vaccines Price by Manufacturers
    • 3.4 Key Manufacturers Malaria Vaccines Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Malaria Vaccines Market
    • 3.6 Key Manufacturers Malaria Vaccines Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Pre-Erythrocytic Vaccine Sales and Revenue (2014-2019)
      • 4.1.2 Erythrocytic Vaccine Sales and Revenue (2014-2019)
      • 4.1.3 Multi-antigen Vaccine Sales and Revenue (2014-2019)
    • 4.2 Global Malaria Vaccines Sales Market Share by Type
    • 4.3 Global Malaria Vaccines Revenue Market Share by Type
    • 4.4 Malaria Vaccines Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Malaria Vaccines Sales by Application

    6 United States

    • 6.1 United States Malaria Vaccines Breakdown Data by Company
    • 6.2 United States Malaria Vaccines Breakdown Data by Type
    • 6.3 United States Malaria Vaccines Breakdown Data by Application

    7 European Union

    • 7.1 European Union Malaria Vaccines Breakdown Data by Company
    • 7.2 European Union Malaria Vaccines Breakdown Data by Type
    • 7.3 European Union Malaria Vaccines Breakdown Data by Application

    8 China

    • 8.1 China Malaria Vaccines Breakdown Data by Company
    • 8.2 China Malaria Vaccines Breakdown Data by Type
    • 8.3 China Malaria Vaccines Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Malaria Vaccines Breakdown Data by Company
    • 9.2 Rest of World Malaria Vaccines Breakdown Data by Type
    • 9.3 Rest of World Malaria Vaccines Breakdown Data by Application
    • 9.4 Rest of World Malaria Vaccines Breakdown Data by Countries
      • 9.4.1 Rest of World Malaria Vaccines Sales by Countries
      • 9.4.2 Rest of World Malaria Vaccines Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GlaxoSmithKline plc
      • 10.1.1 GlaxoSmithKline plc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Malaria Vaccines
      • 10.1.4 Malaria Vaccines Product Introduction
      • 10.1.5 GlaxoSmithKline plc Recent Development
    • 10.2 Sanaria Inc
      • 10.2.1 Sanaria Inc Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Malaria Vaccines
      • 10.2.4 Malaria Vaccines Product Introduction
      • 10.2.5 Sanaria Inc Recent Development
    • 10.3 Nobelpharma Co
      • 10.3.1 Nobelpharma Co Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Malaria Vaccines
      • 10.3.4 Malaria Vaccines Product Introduction
      • 10.3.5 Nobelpharma Co Recent Development
    • 10.4 Sumaya Biotech
      • 10.4.1 Sumaya Biotech Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Malaria Vaccines
      • 10.4.4 Malaria Vaccines Product Introduction
      • 10.4.5 Sumaya Biotech Recent Development
    • 10.5 GenVec
      • 10.5.1 GenVec Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Malaria Vaccines
      • 10.5.4 Malaria Vaccines Product Introduction
      • 10.5.5 GenVec Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Malaria Vaccines Sales Channels
      • 11.2.2 Malaria Vaccines Distributors
    • 11.3 Malaria Vaccines Customers

    12 Market Forecast

    • 12.1 Global Malaria Vaccines Sales and Revenue Forecast 2019-2025
    • 12.2 Global Malaria Vaccines Sales Forecast by Type
    • 12.3 Global Malaria Vaccines Sales Forecast by Application
    • 12.4 Malaria Vaccines Forecast by Regions
      • 12.4.1 Global Malaria Vaccines Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Malaria Vaccines Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Malaria Vaccines are used for malaria treatment.Malaria is a severe and widespread disease caused by a parasitic infection by protozoan Plasmodium when transmitted by various species of anopheles mosquitoes.

      The growing incidence of malaria globally and major players pledging for low profit margin over vaccines is expected to boost growth of the market for malaria vaccines market.
      In 2019, the market size of Malaria Vaccines is million US$ and it will reach million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Malaria Vaccines.

      This report studies the global market size of Malaria Vaccines, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Malaria Vaccines sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      GlaxoSmithKline plc
      Sanaria Inc
      Nobelpharma Co
      Sumaya Biotech
      GenVec
      ...

      Market Segment by Product Type
      Pre-Erythrocytic Vaccine
      Erythrocytic Vaccine
      Multi-antigen Vaccine

      Market Segment by Application
      Hospitals
      Clinics
      Community Centers

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Malaria Vaccines status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Malaria Vaccines manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Malaria Vaccines are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now